PACT Pharma - Assets - Crunchbase Company Profile & Funding

Overview

PACT Pharma - Assets

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About PACT Pharma - Assets

CB Rank

4775916

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.

Acquired by

AmplifyBio

Private

Pharmaceutical

Details

Sub-Organization of

PACT Pharma

Operating Status

Closed

Company Type

For Profit

About the Company

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as private mutations for each patient's cancer as well as creates an opportunity to engineer autologous T cells that target and kill

tumorsexpressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.